FI953549A - Atsa-alifaattisesti silloitetut kinoksaliini-2,3-dionit - Google Patents

Atsa-alifaattisesti silloitetut kinoksaliini-2,3-dionit Download PDF

Info

Publication number
FI953549A
FI953549A FI953549A FI953549A FI953549A FI 953549 A FI953549 A FI 953549A FI 953549 A FI953549 A FI 953549A FI 953549 A FI953549 A FI 953549A FI 953549 A FI953549 A FI 953549A
Authority
FI
Finland
Prior art keywords
azaliphatic
dione
bridged quinoxaline
quinoxaline
bridged
Prior art date
Application number
FI953549A
Other languages
English (en)
Swedish (sv)
Other versions
FI953549A0 (fi
Inventor
Robert Moretti
Kaspar Zimmermann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI953549A0 publication Critical patent/FI953549A0/fi
Publication of FI953549A publication Critical patent/FI953549A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI953549A 1994-07-27 1995-07-24 Atsa-alifaattisesti silloitetut kinoksaliini-2,3-dionit FI953549A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH236694 1994-07-27

Publications (2)

Publication Number Publication Date
FI953549A0 FI953549A0 (fi) 1995-07-24
FI953549A true FI953549A (fi) 1996-01-28

Family

ID=4232111

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953549A FI953549A (fi) 1994-07-27 1995-07-24 Atsa-alifaattisesti silloitetut kinoksaliini-2,3-dionit

Country Status (13)

Country Link
EP (1) EP0705834A1 (fi)
JP (1) JPH0873465A (fi)
KR (1) KR960004346A (fi)
CN (1) CN1117493A (fi)
AU (1) AU2711695A (fi)
BR (1) BR9503458A (fi)
CA (1) CA2154624A1 (fi)
FI (1) FI953549A (fi)
HU (1) HUT73438A (fi)
IL (1) IL114729A0 (fi)
NO (1) NO952959L (fi)
NZ (1) NZ272639A (fi)
ZA (1) ZA956209B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5704898A (en) * 1996-12-16 1998-07-15 Warner-Lambert Company Tricyclic quinoxaline derivatives as neuroprotective agents
AU9651198A (en) 1997-11-11 1999-05-31 Ono Pharmaceutical Co. Ltd. Fused pyrazine compounds
MX2012004769A (es) 2009-10-26 2012-08-08 Warner Chilcott Co Llc Compuestos de bisfosfonato para tratar transtornos del metabolismo oseo.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
HU210264B (en) * 1989-06-09 1995-03-28 Upjohn Co Process for producing amines of condensed ring-systems containing nitrogen and pharmaceutical compositions containing them
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な3環性キノキサリンジオン誘導体
WO1994000124A1 (en) * 1992-06-22 1994-01-06 Eckard Weber Glycine receptor antagonists and the use thereof
EP0664807B1 (en) * 1992-10-13 1997-09-10 Warner-Lambert Company Quinoxalinedione derivatives as eaa antagonists
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones

Also Published As

Publication number Publication date
NZ272639A (en) 1997-05-26
CN1117493A (zh) 1996-02-28
KR960004346A (ko) 1996-02-23
ZA956209B (en) 1996-01-29
NO952959L (no) 1996-01-29
FI953549A0 (fi) 1995-07-24
JPH0873465A (ja) 1996-03-19
CA2154624A1 (en) 1996-01-28
EP0705834A1 (de) 1996-04-10
BR9503458A (pt) 1996-02-27
AU2711695A (en) 1996-02-08
NO952959D0 (no) 1995-07-26
IL114729A0 (en) 1995-11-27
HU9502240D0 (en) 1995-09-28
HUT73438A (en) 1996-07-29

Similar Documents

Publication Publication Date Title
ATE221526T1 (de) 2-hetaroylcyclohexan-1,3-dione
BR9506532A (pt) 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas
DE59814019D1 (de) 2-benzoyl-cyclohexan-1,3-dione
NL1001517A1 (nl) Koppeling.
FI954072A0 (fi) Oksa- tai tia-alifaattisesti silloitetut kinoksaliini-2,3-dionit
NL1001617C2 (nl) Koppeling.
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
FI953549A (fi) Atsa-alifaattisesti silloitetut kinoksaliini-2,3-dionit
NL1001230C1 (nl) Voetsteun.
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
DE59510943D1 (de) 2-Arylcyclopentan-1,3-dion-Derivate
ATE231848T1 (de) Substituierte 2-benzoyl-cyclohexan-1,3-dione
NL1000837C2 (nl) Montagefitting.
NL192999B (nl) Koppeling.
IT234659Y1 (it) Sottosella.
FR2720962B1 (fr) Baguetteuse.
FR2720961B1 (fr) Baguetteuse.
FR2714950B3 (fr) Réducteur-variateur.
ES1028811Y (es) Prenda-zapato integral.
FI944648A0 (fi) Bromsmekanism foer fordon, saerskilt foer en cykel
FI945785A0 (fi) Pimpelspoe, fiskeredokap
FIU940180U0 (fi) Baotstege, kaerra, landgaong
FI1391U1 (fi) Utrymme, saosom bastu av elementkonstruktion
ES1029161Y (es) Ferula.
ES1028803Y (es) Abrazadera.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed